ATE253223T1 - Verfahren und materialien zur diagnose instabiler angina - Google Patents

Verfahren und materialien zur diagnose instabiler angina

Info

Publication number
ATE253223T1
ATE253223T1 AT99943950T AT99943950T ATE253223T1 AT E253223 T1 ATE253223 T1 AT E253223T1 AT 99943950 T AT99943950 T AT 99943950T AT 99943950 T AT99943950 T AT 99943950T AT E253223 T1 ATE253223 T1 AT E253223T1
Authority
AT
Austria
Prior art keywords
materials
methods
unstable angina
stable
unstable
Prior art date
Application number
AT99943950T
Other languages
English (en)
Inventor
Jorg G Goronzy
Cornelia M Weyand
Giovanna Liuzzo
Original Assignee
Mayo Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation filed Critical Mayo Foundation
Application granted granted Critical
Publication of ATE253223T1 publication Critical patent/ATE253223T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99943950T 1998-08-27 1999-08-27 Verfahren und materialien zur diagnose instabiler angina ATE253223T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9812098P 1998-08-27 1998-08-27
PCT/US1999/019536 WO2000013021A1 (en) 1998-08-27 1999-08-27 Methods and materials for diagnosing unstable angina

Publications (1)

Publication Number Publication Date
ATE253223T1 true ATE253223T1 (de) 2003-11-15

Family

ID=22267292

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99943950T ATE253223T1 (de) 1998-08-27 1999-08-27 Verfahren und materialien zur diagnose instabiler angina

Country Status (9)

Country Link
US (2) US6635433B1 (de)
EP (1) EP1108212B1 (de)
JP (1) JP2002523782A (de)
AT (1) ATE253223T1 (de)
AU (1) AU756694B2 (de)
CA (1) CA2341619A1 (de)
DE (1) DE69912453T2 (de)
ES (1) ES2212615T3 (de)
WO (1) WO2000013021A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060094067A1 (en) * 2002-06-26 2006-05-04 Ralf Herwig Method for the determination of characteristics and/or the classification of circulating macrophages, and analysis arrangement for carrying out said method
GB0412859D0 (en) * 2004-06-09 2004-07-14 Immunoclin Ltd Markers for atherosclerosis
US20110195437A1 (en) * 2008-08-04 2011-08-11 Synmed Research Gmbh Method for characterizing, in particular for quantifying, molecular markers that are intracellularly absorbed from tissues by blood macrophages that are recirculated from the tissues into the circulatory system
EP2607899B1 (de) 2011-12-21 2016-08-10 Beckman Coulter, Inc. Verfahren zur Markierung intrazellulärer und extrazellulärer Zielstrukturen von Leukozyten
US11864560B2 (en) 2022-01-21 2024-01-09 Richard Thomas Johnston Fragrant plant treatment compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022819A1 (en) * 1991-06-14 1992-12-23 Board Of Regents Of The University Of Washington Diagnosis and treatment of arterial chlamydial granuloma
US5968770A (en) * 1995-02-10 1999-10-19 Millennium Pharmaceuticals, Inc. Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target
DK1493439T3 (da) * 1997-04-02 2012-01-30 Brigham & Womens Hospital Middel til fastlæggelse af en persons risikoprofil for aterosklerotisk sygdom

Also Published As

Publication number Publication date
US20050260690A1 (en) 2005-11-24
AU756694B2 (en) 2003-01-23
EP1108212A1 (de) 2001-06-20
EP1108212A4 (de) 2001-09-19
DE69912453D1 (de) 2003-12-04
JP2002523782A (ja) 2002-07-30
AU5694099A (en) 2000-03-21
ES2212615T3 (es) 2004-07-16
CA2341619A1 (en) 2000-03-09
DE69912453T2 (de) 2004-07-22
US6635433B1 (en) 2003-10-21
US7244579B2 (en) 2007-07-17
WO2000013021A1 (en) 2000-03-09
EP1108212B1 (de) 2003-10-29

Similar Documents

Publication Publication Date Title
AU4694499A (en) Trace level detection of analytes using artificial olfactometry
AU1929199A (en) Methods for the recovery and measurement of troponin complexes
ATE310955T1 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
WO2005052542A3 (en) Method and composition useful for determining fk 506
TWI256975B (en) Compositions containing a urea derivative dye for detecting an analyte and methods for using the same
AU4932099A (en) Methods for fractional quantification of cholesterol in lipoproteins and quantification reagents
FI915150A7 (fi) Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi
CY1111863T1 (el) Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων
EP1373567A4 (de) "nachweis von sequenzen, die reich an methyliertem cpg sind, zur diagnose maligner zellen"
WO2002067760A3 (en) Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
DE60228557D1 (de) Candida-nachweis
DE69836493D1 (de) Vorrichtung zur bestimmung von mehreren analyten
ES2079481T3 (es) Un procedimiento para la determinacion de la actividad funcional de la proteina s o de la proteina c libre en una muestra de plasma.
BR0014150A (pt) Diagnósticos e terapêuticos para osteoporose
AU2003259222A1 (en) Method of diagnosing alzheimer's disease
BR0014626A (pt) Análise de leptina
ATE253223T1 (de) Verfahren und materialien zur diagnose instabiler angina
DE50007635D1 (de) Verfahren zur diagnose von sjögren-syndrom
WO2002059600A3 (en) Analyte detection
FR2795823B1 (fr) Methodes et kits pour le diagnostic ou le suivi d'une pathologie synoviale ou osteoarticulaire comprenant l'utilisation d'un marqueur specifique de la degradation du tissu synovial
EP0836652A4 (de) Methoden, probensätze und zusammensetzungen für den nachweis von papillomavirus
EP0899541A3 (de) Apparat zur Bestimmung der Dicke eines optischen Prüfkörpers
DE60127901D1 (de) TCF-1 Nukleotidsequenzvariation
MXPA04003084A (es) Portador de muestras con pinzas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1108212

Country of ref document: EP

REN Ceased due to non-payment of the annual fee